This activity is designed to meet the educational needs of physicians, nurses, and advanced practice clinicians who manage patients with multiple sclerosis (MS).
MS care providers need to continually update best practices and procedures to accommodate guideline changes, research developments, and new therapeutic strategies. Among the newer guidelines are the updated McDonald Diagnostic Criteria for MS released in December 2017, and MRI criteria revised in 2017 and 2018. The new guidelines present updates to some of the elements that were vital to diagnosing MS in the past. How does this change the diagnostic workup? Does it allow for earlier diagnosis and treatment—and if so, for which patients? Bruce A. Cohen, MD, a recognized expert in the field of MS management will break down these questions and present cases that illustrate new guideline changes in practice.
Program Chair and Moderator
Amy Perrin Ross, APN, MSN, CNRN, MSCN
Neuroscience Program Coordinator
Loyola University Medical Center
Bruce A. Cohen, MD
Professor of Neurology
Director, Multiple Sclerosis Program
Feinberg School of Medicine
Accreditation and Credit Statements
In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and Delaware Media Group. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The CMSC designates this journal-based activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The CMSC designates this enduring material for 1.0 contact hour (none in the area of pharmacology).
This activity is supported by an educational grant from Genentech.
Release date: 1/22/19. Valid for credit through: 1/23/20.